Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-263252
Filing Date
2007-12-12
Accepted
2007-12-11 18:59:24
Documents
9
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1081552
2 ASSET PURCHASE AGREEMENT BETWEEN VALERA AND ANTHRA PHARMACEUTICALS dex10173.htm EX-10.173 115659
3 COLLABORATION & DEVELOPMENT AGREEMENT (VALERA & ALPEX PHARMA) 4/6/05 dex10180.htm EX-10.180 217236
4 LIST OF SUBSIDIARIES dex21.htm EX-21 4100
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 1704
6 CERTIFICATION OF PEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9744
7 CERTIFICATION OF PFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9748
8 CERTIFICATION OF PEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 2915
9 CERTIFICATION OF PFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2886
  Complete submission text file 0001193125-07-263252.txt   1447037
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 6178618444
INDEVUS PHARMACEUTICALS INC (Filer) CIK: 0000854222 (see all company filings)

EIN.: 043047911 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-18728 | Film No.: 071300094
SIC: 2834 Pharmaceutical Preparations